• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

饮食和体育锻炼是通过改善胰岛素抵抗和代谢灵活性来应对代谢功能障碍相关脂肪性肝病的关键因素。

Diet and physical exercise as key players to tackle MASLD through improvement of insulin resistance and metabolic flexibility.

作者信息

Mambrini Sara Paola, Grillo Antonio, Colosimo Santo, Zarpellon Francesco, Pozzi Giorgia, Furlan Davide, Amodeo Gabriele, Bertoli Simona

机构信息

Nutrition Science Research Lab, Ospedale S. Giuseppe, Istituto Auxologico Italiano IRCCS, Piancavallo, Italy.

Istituto Auxologico Italiano IRCCS, Piancavallo, Italy.

出版信息

Front Nutr. 2024 Aug 20;11:1426551. doi: 10.3389/fnut.2024.1426551. eCollection 2024.

DOI:10.3389/fnut.2024.1426551
PMID:39229589
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11370663/
Abstract

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) has emerged as a prevalent health concern, encompassing a wide spectrum of liver-related disorders. Insulin resistance, a key pathophysiological feature of MASLD, can be effectively ameliorated through dietary interventions. The Mediterranean diet, rich in whole grains, fruits, vegetables, legumes, and healthy fats, has shown promising results in improving insulin sensitivity. Several components of the Mediterranean diet, such as monounsaturated fats and polyphenols, exert anti-inflammatory and antioxidant effects, thereby reducing hepatic steatosis and inflammation. Furthermore, this dietary pattern has been associated with a higher likelihood of achieving MASLD remission. In addition to dietary modifications, physical exercise, particularly resistance exercise, plays a crucial role in enhancing metabolic flexibility. Resistance exercise training promotes the utilization of fatty acids as an energy source. It enhances muscle glucose uptake and glycogen storage, thus reducing the burden on the liver to uptake excess blood glucose. Furthermore, resistance exercise stimulates muscle protein synthesis, contributing to an improved muscle-to-fat ratio and overall metabolic health. When implemented synergistically, the Mediterranean diet and resistance exercise can elicit complementary effects in combating MASLD. Combined interventions have demonstrated additive benefits, including greater improvements in insulin resistance, increased metabolic flexibility, and enhanced potential for MASLD remission. This underscores the importance of adopting a multifaceted approach encompassing dietary modifications and regular physical exercise to effectively manage MASLD. This narrative review explores the biological mechanisms of diet and physical exercise in addressing MASLD by targeting insulin resistance and decreased metabolic flexibility.

摘要

代谢功能障碍相关脂肪性肝病(MASLD)已成为一个普遍的健康问题,涵盖了广泛的肝脏相关疾病。胰岛素抵抗是MASLD的一个关键病理生理特征,可通过饮食干预有效改善。富含全谷物、水果、蔬菜、豆类和健康脂肪的地中海饮食,在改善胰岛素敏感性方面已显示出有希望的结果。地中海饮食的几个成分,如单不饱和脂肪和多酚,具有抗炎和抗氧化作用,从而减少肝脏脂肪变性和炎症。此外,这种饮食模式与实现MASLD缓解的可能性更高有关。除了饮食调整外,体育锻炼,特别是抗阻运动,在增强代谢灵活性方面起着关键作用。抗阻运动训练促进脂肪酸作为能量来源的利用。它增强肌肉对葡萄糖的摄取和糖原储存,从而减轻肝脏摄取过量血糖的负担。此外,抗阻运动刺激肌肉蛋白质合成,有助于改善肌肉与脂肪的比例和整体代谢健康。当协同实施时,地中海饮食和抗阻运动在对抗MASLD方面可产生互补作用。联合干预已显示出累加益处,包括胰岛素抵抗的更大改善、代谢灵活性增加以及MASLD缓解的可能性增强。这凸显了采用包括饮食调整和定期体育锻炼的多方面方法来有效管理MASLD的重要性。这篇叙述性综述探讨了饮食和体育锻炼通过针对胰岛素抵抗和代谢灵活性降低来解决MASLD的生物学机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d7a/11370663/17012cd87ea0/fnut-11-1426551-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d7a/11370663/6d7f1d56ba97/fnut-11-1426551-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d7a/11370663/17012cd87ea0/fnut-11-1426551-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d7a/11370663/6d7f1d56ba97/fnut-11-1426551-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d7a/11370663/17012cd87ea0/fnut-11-1426551-g002.jpg

相似文献

1
Diet and physical exercise as key players to tackle MASLD through improvement of insulin resistance and metabolic flexibility.饮食和体育锻炼是通过改善胰岛素抵抗和代谢灵活性来应对代谢功能障碍相关脂肪性肝病的关键因素。
Front Nutr. 2024 Aug 20;11:1426551. doi: 10.3389/fnut.2024.1426551. eCollection 2024.
2
Unlocking liver health: Can tackling myosteatosis spark remission in metabolic dysfunction-associated steatotic liver disease?解锁肝脏健康:解决肌内脂肪变性能否引发代谢功能障碍相关脂肪性肝病的缓解?
Liver Int. 2024 Aug;44(8):1781-1796. doi: 10.1111/liv.15938. Epub 2024 Apr 16.
3
Mediterranean diet for the management of metabolic dysfunction-associated steatotic liver disease in non-Mediterranean, Western countries: What's known and what's needed?地中海饮食在非地中海、西方国家代谢相关脂肪性肝病中的应用:已知和需要了解的内容?
Nutr Bull. 2024 Dec;49(4):444-462. doi: 10.1111/nbu.12707. Epub 2024 Sep 11.
4
Metabolic-Dysfunction-Associated Steatotic Liver Disease-Its Pathophysiology, Association with Atherosclerosis and Cardiovascular Disease, and Treatments.代谢功能障碍相关性脂肪性肝病及其病理生理学、与动脉粥样硬化和心血管疾病的关联,以及治疗方法。
Int J Mol Sci. 2023 Oct 23;24(20):15473. doi: 10.3390/ijms242015473.
5
Exercise enhances hepatic mitochondrial structure and function while preventing endoplasmic reticulum stress and metabolic dysfunction-associated steatotic liver disease in mice fed a high-fat diet.运动增强了高脂肪饮食喂养的小鼠的肝线粒体结构和功能,同时预防内质网应激和代谢功能障碍相关的脂肪性肝病。
Nutr Res. 2024 Jun;126:180-192. doi: 10.1016/j.nutres.2024.04.002. Epub 2024 Apr 16.
6
Vitamin D and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Novel Mechanistic Insights.维生素 D 与代谢相关脂肪性肝病(MASLD):新的机制见解。
Int J Mol Sci. 2024 Apr 30;25(9):4901. doi: 10.3390/ijms25094901.
7
Diet, exercise, and supplements: what is their role in the management of the metabolic dysfunction-associated steatotic liver disease in children?饮食、运动和补充剂:在儿童代谢功能障碍相关脂肪性肝病的管理中,它们各自扮演什么角色?
Endocrine. 2024 Sep;85(3):988-1006. doi: 10.1007/s12020-024-03783-7. Epub 2024 Mar 22.
8
Management of Metabolic-Associated Fatty Liver Disease/Metabolic Dysfunction-Associated Steatotic Liver Disease: From Medication Therapy to Nutritional Interventions.代谢相关性脂肪性肝病/代谢相关脂肪性肝病的管理:从药物治疗到营养干预。
Nutrients. 2024 Jul 11;16(14):2220. doi: 10.3390/nu16142220.
9
Non-Pharmacological Approach to Diet and Exercise in Metabolic-Associated Fatty Liver Disease: Bridging the Gap between Research and Clinical Practice.代谢相关脂肪性肝病饮食与运动的非药物治疗方法:弥合研究与临床实践之间的差距
J Pers Med. 2024 Jan 1;14(1):61. doi: 10.3390/jpm14010061.
10
The Associations between Healthy Eating Patterns and Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Case-Control Study.健康饮食习惯与代谢相关脂肪性肝病风险的关联:病例对照研究。
Nutrients. 2024 Jun 19;16(12):1956. doi: 10.3390/nu16121956.

引用本文的文献

1
Exercise-Induced Muscle-Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging.运动诱导的肌肉-脂肪相互作用:分子介质及其药理学调节对维持衰老过程中代谢灵活性的作用
Pharmaceuticals (Basel). 2025 Aug 19;18(8):1222. doi: 10.3390/ph18081222.
2
Physical Activity and Metabolic Disorders-What Does Gut Microbiota Have to Do with It?体力活动与代谢紊乱——肠道微生物群与此有何关联?
Curr Issues Mol Biol. 2025 Aug 7;47(8):630. doi: 10.3390/cimb47080630.
3
Ketogenic diet ameliorates MASLD via balancing mitochondrial dynamics and improving mitochondrial dysfunction.

本文引用的文献

1
EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).EASL-EASD-EASO 临床实践指南:代谢功能障碍相关脂肪性肝病(MASLD)的管理。
J Hepatol. 2024 Sep;81(3):492-542. doi: 10.1016/j.jhep.2024.04.031. Epub 2024 Jun 7.
2
Resmetirom, the first approved drug for the management of metabolic dysfunction-associated steatohepatitis: Trials, opportunities, and challenges.瑞美替隆,首个获批用于治疗代谢功能障碍相关脂肪性肝炎的药物:试验、机遇与挑战。
Metabolism. 2024 May;154:155835. doi: 10.1016/j.metabol.2024.155835. Epub 2024 Mar 19.
3
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
生酮饮食通过平衡线粒体动力学和改善线粒体功能障碍来改善代谢相关脂肪性肝病。
Nutr Diabetes. 2025 Aug 25;15(1):37. doi: 10.1038/s41387-025-00391-w.
4
The Impact of Social Determinants of Health on Metabolic Dysfunction-Associated Steatotic Liver Disease Among Adults in the United States.社会健康决定因素对美国成年人代谢功能障碍相关脂肪性肝病的影响
J Clin Med. 2025 Aug 4;14(15):5484. doi: 10.3390/jcm14155484.
5
Metabolic Dysfunction-Associated Steatotic Liver Disease Is Characterized by Enhanced Endogenous Cholesterol Synthesis and Impaired Synthesis/Absorption Balance.代谢功能障碍相关脂肪性肝病的特征是内源性胆固醇合成增强以及合成/吸收平衡受损。
Int J Mol Sci. 2025 Aug 1;26(15):7462. doi: 10.3390/ijms26157462.
6
Alcohol Consumption and Liver Metabolism in the Era of MASLD: Integrating Nutritional and Pathophysiological Insights.代谢相关脂肪性肝病时代的酒精消费与肝脏代谢:整合营养与病理生理学见解
Nutrients. 2025 Jul 5;17(13):2229. doi: 10.3390/nu17132229.
7
Effects of Exercise Intervention in Subjects with Metabolic Dysfunction-Associated Steatotic Liver Disease.运动干预对代谢功能障碍相关脂肪性肝病患者的影响。
J Obes Metab Syndr. 2025 Jul 30;34(3):239-252. doi: 10.7570/jomes25028. Epub 2025 Jul 11.
8
Association between Life's Crucial 9 and metabolic dysfunction-associated steatotic liver disease: the mediating role of neutrophil-percentage-to-albumin ratio.生命关键9与代谢功能障碍相关脂肪性肝病之间的关联:中性粒细胞百分比与白蛋白比值的中介作用
Front Nutr. 2025 Jun 6;12:1549089. doi: 10.3389/fnut.2025.1549089. eCollection 2025.
9
The association between lifelines diet score and metabolic associated fatty liver disease: a case-control study.生命线饮食评分与代谢相关脂肪性肝病之间的关联:一项病例对照研究。
Front Nutr. 2025 May 15;12:1569814. doi: 10.3389/fnut.2025.1569814. eCollection 2025.
10
Exploring the association between dietary indices and metabolic dysfunction-associated steatotic liver disease: Mediation analysis and evidence from NHANES.探索饮食指数与代谢功能障碍相关脂肪性肝病之间的关联:中介分析及来自美国国家健康与营养检查调查(NHANES)的证据
PLoS One. 2025 Apr 17;20(4):e0321251. doi: 10.1371/journal.pone.0321251. eCollection 2025.
一项评估 Resmetirom 治疗伴有肝纤维化的 NASH 的 3 期随机对照试验。
N Engl J Med. 2024 Feb 8;390(6):497-509. doi: 10.1056/NEJMoa2309000.
4
Insulin resistance and metabolic flexibility as drivers of liver and cardiac disease in T2DM.胰岛素抵抗和代谢灵活性作为2型糖尿病中肝脏和心脏疾病的驱动因素。
Diabetes Res Clin Pract. 2023 Dec;206:111016. doi: 10.1016/j.diabres.2023.111016. Epub 2023 Nov 17.
5
Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: Focus on the adipose tissue, liver, and pancreas.过氧化物酶体增殖物激活受体作为治疗代谢性疾病的靶点:聚焦脂肪组织、肝脏和胰腺。
World J Gastroenterol. 2023 Jul 14;29(26):4136-4155. doi: 10.3748/wjg.v29.i26.4136.
6
Editorial: should NAFLD be included in the definition of Metabolic Syndrome?社论:非酒精性脂肪性肝病是否应纳入代谢综合征的定义?
Aliment Pharmacol Ther. 2023 May;57(10):1151-1152. doi: 10.1111/apt.17411.
7
Improved glycaemic control in patients with type 2 diabetes has a beneficial impact on NAFLD, independent of change in BMI or glucose lowering agent.改善 2 型糖尿病患者的血糖控制对 NAFLD 有有益影响,与 BMI 变化或降血糖药物无关。
Nutr Metab Cardiovasc Dis. 2023 Mar;33(3):640-648. doi: 10.1016/j.numecd.2022.12.010. Epub 2022 Dec 21.
8
PGC-1α affects skeletal muscle and adipose tissue development by regulating mitochondrial biogenesis.PGC-1α 通过调节线粒体生物发生影响骨骼肌和脂肪组织的发育。
Mol Genet Genomics. 2022 May;297(3):621-633. doi: 10.1007/s00438-022-01878-2. Epub 2022 Mar 15.
9
Effects of Diet, Lifestyle, Chrononutrition and Alternative Dietary Interventions on Postprandial Glycemia and Insulin Resistance.饮食、生活方式、时间营养和替代饮食干预对餐后血糖和胰岛素抵抗的影响。
Nutrients. 2022 Feb 16;14(4):823. doi: 10.3390/nu14040823.
10
Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma.非酒精性脂肪性肝病与肝细胞癌的流行病学
JHEP Rep. 2021 May 11;3(4):100305. doi: 10.1016/j.jhepr.2021.100305. eCollection 2021 Aug.